Who is sponsoring NCT06980233?

NCT06980233 is sponsored by Meaningful Measurement, Inc.

What drugs are being tested in NCT06980233?

Interventions in NCT06980233: reentry assistance mobile health app.

What condition does NCT06980233 study?

NCT06980233 studies Substance Use Disorder (SUD), Mental Health Disorder, Criminal Recidivism.

Is NCT06980233 still recruiting?

NCT06980233 is currently active, enrolled. Last updated 3 April 2026.

Last reviewed 2026-04-03 · How we verify

NCT06980233: R-Assist

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reentry Assist (R-Assist)

Active, enrolled NA Last updated 3 April 2026

What this trial tests

NA trial testing reentry assistance mobile health app in Substance Use Disorder (SUD) in 38 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 June 2025

Primary endpoint
31 March 2026

30 April 2026

Quick facts

Lead sponsor	Meaningful Measurement, Inc
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	38
Start date	1 June 2025
Primary completion	31 March 2026
Estimated completion	30 April 2026
Sites	1 location across United States

Drugs / interventions tested

reentry assistance mobile health app

Conditions studied

Substance Use Disorder (SUD) — all drugs for Substance Use Disorder (SUD) →
Mental Health Disorder — all drugs for Mental Health Disorder →
Criminal Recidivism — all drugs for Criminal Recidivism →

Sponsor

Meaningful Measurement, Inc

Who can join

18 and older, any sex, with Substance Use Disorder (SUD) or Mental Health Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will aim to develop and pilot test, R-Assist, a mobile health application to support individuals with co-occurring substance use and mental health disorders (COD) in their recovery, who have recently released from a participating Massachusetts jail.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Substance Use Disorder (SUD)

Currently open trials in the same condition.

NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START · recruiting
NCT07503067 — Identifying Substance Use Consequences · recruiting
NCT06790641 — Pathways to Perinatal Mental Health Equity · NA · recruiting
NCT07433985 — California MEPS Hub · NA · recruiting
NCT07214467 — Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06980233 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Meaningful Measurement, Inc
Last refreshed: 3 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06980233.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing